D-0661-2017 Class II Terminated

Recalled by Akorn, Inc. — Lake Forest, IL

FDA drug recall D-0661-2017 was initiated by Akorn, Inc. on Mar 17, 2017 and is designated Class II. Reason for recall: Lack of assurance of sterility: product was found to be empty, under-filled, or leaking. The recall status is terminated (terminated Jul 9, 2019). Affected quantity: 107,940 bottles.

Recall details

Product Type
Drugs
Report Date
Apr 19, 2017
Initiation Date
Mar 17, 2017
Termination Date
Jul 9, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
107,940 bottles

Product description

LATANOPROST OPHTHALMIC SOLUTION, 0.005%, 125 ug/2.5 mL, packaged in 2.5 mL bottle, Rx only, Manufactured for: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-625-12

Reason for recall

Lack of assurance of sterility: product was found to be empty, under-filled, or leaking.

Distribution pattern

Nationwide

Code information

Lot # LAB15G52, LAB11G52, Exp 6/17; LAB18I52, Exp 8/17; LAB9L52, 11/17; LAB1A62, LAB9A62, Exp 12/17

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0661-2017
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0661-2017. Report a data issue: hello@regdatalab.com.